Details for New Drug Application (NDA): 200671
✉ Email this page to a colleague
NDA 200671 describes DURLAZA, which is a drug marketed by Hesp and is included in one NDA. Additional details are available on the DURLAZA profile page.
The generic ingredient in DURLAZA is aspirin. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin profile page.
The generic ingredient in DURLAZA is aspirin. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin profile page.
Medical Subject Heading (MeSH) Categories for 200671
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 162.5MG | ||||
| Approval Date: | Sep 4, 2015 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
